ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
2
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
2
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Circulating Tumor Cell(CTC)Detection Market Research Report 2024
Published Date: October 2024
|
Report Code: QYRE-Auto-3E18543
Home | Market Reports | Health| Health Conditions| Cancer
Global Circulating Tumor Cell CTC Detection Market Research Report 2024
BUY CHAPTERS

Global Circulating Tumor Cell(CTC)Detection Market Research Report 2024

Code: QYRE-Auto-3E18543
Report
October 2024
Pages:77
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
CTC
RareCyte
Angle plc
Biocept
Bio-Rad Laboratories Inc
Fluxion Biosciences Inc.
F. Hoffmann-La Roche AG
Sysmex Europe SE
Qiagen NV

Circulating Tumor Cell(CTC)Detection Market

The free tumor cell (CTC) test is a method used to detect and analyze tumor cells circulating in the blood. CTCs are cancer cells that fall off from the primary tumor and enter the blood circulation. By detecting these cells, important information about cancer progression, metastasis risk, and treatment efficacy can be provided. CTC detection is a non-invasive liquid biopsy technology that can monitor the development of cancer in real time and help doctors optimize personalized treatment plans. It is particularly suitable for early diagnosis of cancer, prediction of recurrence, and efficacy evaluation.
The global Circulating Tumor Cell(CTC)Detection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Circulating Tumor Cell(CTC)Detection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Circulating Tumor Cell(CTC)Detection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Circulating Tumor Cell(CTC)Detection in Cancer Diagnosis is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Circulating Tumor Cell(CTC)Detection include Rarecyte, ANGLE plc, Biocept Inc., Bio-Rad Laboratories Inc., Fluxion Biosciences Inc., F. Hoffmann-La Roche AG, Sysmex Europe SE, Qiagen, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Circulating Tumor Cell(CTC)Detection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Circulating Tumor Cell(CTC)Detection.
The Circulating Tumor Cell(CTC)Detection market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Circulating Tumor Cell(CTC)Detection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Circulating Tumor Cell(CTC)Detection companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Circulating Tumor Cell(CTC)Detection Market Report

Report Metric Details
Report Name Circulating Tumor Cell(CTC)Detection Market
Segment by Type
  • Epithelial Cell Phenotype
  • Mesenchymal Cell Phenotype
  • Mixed Epithelial-Mesenchymal Phenotype
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Rarecyte, ANGLE plc, Biocept Inc., Bio-Rad Laboratories Inc., Fluxion Biosciences Inc., F. Hoffmann-La Roche AG, Sysmex Europe SE, Qiagen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Circulating Tumor Cell(CTC)Detection company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Circulating Tumor Cell(CTC)Detection Market report?

Ans: The main players in the Circulating Tumor Cell(CTC)Detection Market are Rarecyte, ANGLE plc, Biocept Inc., Bio-Rad Laboratories Inc., Fluxion Biosciences Inc., F. Hoffmann-La Roche AG, Sysmex Europe SE, Qiagen

What are the Application segmentation covered in the Circulating Tumor Cell(CTC)Detection Market report?

Ans: The Applications covered in the Circulating Tumor Cell(CTC)Detection Market report are Cancer Diagnosis, Tumor Dynamic Assessment, Tumor Recurrence Monitoring

What are the Type segmentation covered in the Circulating Tumor Cell(CTC)Detection Market report?

Ans: The Types covered in the Circulating Tumor Cell(CTC)Detection Market report are Epithelial Cell Phenotype, Mesenchymal Cell Phenotype, Mixed Epithelial-Mesenchymal Phenotype

Recommended Reports

Liquid Biopsy Markets

ctDNA & CTC Detection

Cancer Diagnostics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Circulating Tumor Cell(CTC)Detection Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Epithelial Cell Phenotype
1.2.3 Mesenchymal Cell Phenotype
1.2.4 Mixed Epithelial-Mesenchymal Phenotype
1.3 Market by Application
1.3.1 Global Circulating Tumor Cell(CTC)Detection Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cancer Diagnosis
1.3.3 Tumor Dynamic Assessment
1.3.4 Tumor Recurrence Monitoring
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Circulating Tumor Cell(CTC)Detection Market Perspective (2019-2030)
2.2 Global Circulating Tumor Cell(CTC)Detection Growth Trends by Region
2.2.1 Global Circulating Tumor Cell(CTC)Detection Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Circulating Tumor Cell(CTC)Detection Historic Market Size by Region (2019-2024)
2.2.3 Circulating Tumor Cell(CTC)Detection Forecasted Market Size by Region (2025-2030)
2.3 Circulating Tumor Cell(CTC)Detection Market Dynamics
2.3.1 Circulating Tumor Cell(CTC)Detection Industry Trends
2.3.2 Circulating Tumor Cell(CTC)Detection Market Drivers
2.3.3 Circulating Tumor Cell(CTC)Detection Market Challenges
2.3.4 Circulating Tumor Cell(CTC)Detection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Circulating Tumor Cell(CTC)Detection Players by Revenue
3.1.1 Global Top Circulating Tumor Cell(CTC)Detection Players by Revenue (2019-2024)
3.1.2 Global Circulating Tumor Cell(CTC)Detection Revenue Market Share by Players (2019-2024)
3.2 Global Circulating Tumor Cell(CTC)Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Circulating Tumor Cell(CTC)Detection Revenue
3.4 Global Circulating Tumor Cell(CTC)Detection Market Concentration Ratio
3.4.1 Global Circulating Tumor Cell(CTC)Detection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cell(CTC)Detection Revenue in 2023
3.5 Global Key Players of Circulating Tumor Cell(CTC)Detection Head office and Area Served
3.6 Global Key Players of Circulating Tumor Cell(CTC)Detection, Product and Application
3.7 Global Key Players of Circulating Tumor Cell(CTC)Detection, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Circulating Tumor Cell(CTC)Detection Breakdown Data by Type
4.1 Global Circulating Tumor Cell(CTC)Detection Historic Market Size by Type (2019-2024)
4.2 Global Circulating Tumor Cell(CTC)Detection Forecasted Market Size by Type (2025-2030)
5 Circulating Tumor Cell(CTC)Detection Breakdown Data by Application
5.1 Global Circulating Tumor Cell(CTC)Detection Historic Market Size by Application (2019-2024)
5.2 Global Circulating Tumor Cell(CTC)Detection Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Circulating Tumor Cell(CTC)Detection Market Size (2019-2030)
6.2 North America Circulating Tumor Cell(CTC)Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Circulating Tumor Cell(CTC)Detection Market Size by Country (2019-2024)
6.4 North America Circulating Tumor Cell(CTC)Detection Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Circulating Tumor Cell(CTC)Detection Market Size (2019-2030)
7.2 Europe Circulating Tumor Cell(CTC)Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Circulating Tumor Cell(CTC)Detection Market Size by Country (2019-2024)
7.4 Europe Circulating Tumor Cell(CTC)Detection Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Circulating Tumor Cell(CTC)Detection Market Size (2019-2030)
8.2 Asia-Pacific Circulating Tumor Cell(CTC)Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Circulating Tumor Cell(CTC)Detection Market Size by Region (2019-2024)
8.4 Asia-Pacific Circulating Tumor Cell(CTC)Detection Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Circulating Tumor Cell(CTC)Detection Market Size (2019-2030)
9.2 Latin America Circulating Tumor Cell(CTC)Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Circulating Tumor Cell(CTC)Detection Market Size by Country (2019-2024)
9.4 Latin America Circulating Tumor Cell(CTC)Detection Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Size (2019-2030)
10.2 Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Size by Country (2019-2024)
10.4 Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Rarecyte
11.1.1 Rarecyte Company Details
11.1.2 Rarecyte Business Overview
11.1.3 Rarecyte Circulating Tumor Cell(CTC)Detection Introduction
11.1.4 Rarecyte Revenue in Circulating Tumor Cell(CTC)Detection Business (2019-2024)
11.1.5 Rarecyte Recent Development
11.2 ANGLE plc
11.2.1 ANGLE plc Company Details
11.2.2 ANGLE plc Business Overview
11.2.3 ANGLE plc Circulating Tumor Cell(CTC)Detection Introduction
11.2.4 ANGLE plc Revenue in Circulating Tumor Cell(CTC)Detection Business (2019-2024)
11.2.5 ANGLE plc Recent Development
11.3 Biocept Inc.
11.3.1 Biocept Inc. Company Details
11.3.2 Biocept Inc. Business Overview
11.3.3 Biocept Inc. Circulating Tumor Cell(CTC)Detection Introduction
11.3.4 Biocept Inc. Revenue in Circulating Tumor Cell(CTC)Detection Business (2019-2024)
11.3.5 Biocept Inc. Recent Development
11.4 Bio-Rad Laboratories Inc.
11.4.1 Bio-Rad Laboratories Inc. Company Details
11.4.2 Bio-Rad Laboratories Inc. Business Overview
11.4.3 Bio-Rad Laboratories Inc. Circulating Tumor Cell(CTC)Detection Introduction
11.4.4 Bio-Rad Laboratories Inc. Revenue in Circulating Tumor Cell(CTC)Detection Business (2019-2024)
11.4.5 Bio-Rad Laboratories Inc. Recent Development
11.5 Fluxion Biosciences Inc.
11.5.1 Fluxion Biosciences Inc. Company Details
11.5.2 Fluxion Biosciences Inc. Business Overview
11.5.3 Fluxion Biosciences Inc. Circulating Tumor Cell(CTC)Detection Introduction
11.5.4 Fluxion Biosciences Inc. Revenue in Circulating Tumor Cell(CTC)Detection Business (2019-2024)
11.5.5 Fluxion Biosciences Inc. Recent Development
11.6 F. Hoffmann-La Roche AG
11.6.1 F. Hoffmann-La Roche AG Company Details
11.6.2 F. Hoffmann-La Roche AG Business Overview
11.6.3 F. Hoffmann-La Roche AG Circulating Tumor Cell(CTC)Detection Introduction
11.6.4 F. Hoffmann-La Roche AG Revenue in Circulating Tumor Cell(CTC)Detection Business (2019-2024)
11.6.5 F. Hoffmann-La Roche AG Recent Development
11.7 Sysmex Europe SE
11.7.1 Sysmex Europe SE Company Details
11.7.2 Sysmex Europe SE Business Overview
11.7.3 Sysmex Europe SE Circulating Tumor Cell(CTC)Detection Introduction
11.7.4 Sysmex Europe SE Revenue in Circulating Tumor Cell(CTC)Detection Business (2019-2024)
11.7.5 Sysmex Europe SE Recent Development
11.8 Qiagen
11.8.1 Qiagen Company Details
11.8.2 Qiagen Business Overview
11.8.3 Qiagen Circulating Tumor Cell(CTC)Detection Introduction
11.8.4 Qiagen Revenue in Circulating Tumor Cell(CTC)Detection Business (2019-2024)
11.8.5 Qiagen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
CTC
RareCyte
Angle plc
Biocept
Bio-Rad Laboratories Inc
Fluxion Biosciences Inc.
F. Hoffmann-La Roche AG
Sysmex Europe SE
Qiagen NV
List of Tables
 Table 1. Global Circulating Tumor Cell(CTC)Detection Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Epithelial Cell Phenotype
 Table 3. Key Players of Mesenchymal Cell Phenotype
 Table 4. Key Players of Mixed Epithelial-Mesenchymal Phenotype
 Table 5. Global Circulating Tumor Cell(CTC)Detection Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global Circulating Tumor Cell(CTC)Detection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 7. Global Circulating Tumor Cell(CTC)Detection Market Size by Region (2019-2024) & (US$ Million)
 Table 8. Global Circulating Tumor Cell(CTC)Detection Market Share by Region (2019-2024)
 Table 9. Global Circulating Tumor Cell(CTC)Detection Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 10. Global Circulating Tumor Cell(CTC)Detection Market Share by Region (2025-2030)
 Table 11. Circulating Tumor Cell(CTC)Detection Market Trends
 Table 12. Circulating Tumor Cell(CTC)Detection Market Drivers
 Table 13. Circulating Tumor Cell(CTC)Detection Market Challenges
 Table 14. Circulating Tumor Cell(CTC)Detection Market Restraints
 Table 15. Global Circulating Tumor Cell(CTC)Detection Revenue by Players (2019-2024) & (US$ Million)
 Table 16. Global Circulating Tumor Cell(CTC)Detection Market Share by Players (2019-2024)
 Table 17. Global Top Circulating Tumor Cell(CTC)Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cell(CTC)Detection as of 2023)
 Table 18. Ranking of Global Top Circulating Tumor Cell(CTC)Detection Companies by Revenue (US$ Million) in 2023
 Table 19. Global 5 Largest Players Market Share by Circulating Tumor Cell(CTC)Detection Revenue (CR5 and HHI) & (2019-2024)
 Table 20. Global Key Players of Circulating Tumor Cell(CTC)Detection, Headquarters and Area Served
 Table 21. Global Key Players of Circulating Tumor Cell(CTC)Detection, Product and Application
 Table 22. Global Key Players of Circulating Tumor Cell(CTC)Detection, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Circulating Tumor Cell(CTC)Detection Market Size by Type (2019-2024) & (US$ Million)
 Table 25. Global Circulating Tumor Cell(CTC)Detection Revenue Market Share by Type (2019-2024)
 Table 26. Global Circulating Tumor Cell(CTC)Detection Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 27. Global Circulating Tumor Cell(CTC)Detection Revenue Market Share by Type (2025-2030)
 Table 28. Global Circulating Tumor Cell(CTC)Detection Market Size by Application (2019-2024) & (US$ Million)
 Table 29. Global Circulating Tumor Cell(CTC)Detection Revenue Market Share by Application (2019-2024)
 Table 30. Global Circulating Tumor Cell(CTC)Detection Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 31. Global Circulating Tumor Cell(CTC)Detection Revenue Market Share by Application (2025-2030)
 Table 32. North America Circulating Tumor Cell(CTC)Detection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 33. North America Circulating Tumor Cell(CTC)Detection Market Size by Country (2019-2024) & (US$ Million)
 Table 34. North America Circulating Tumor Cell(CTC)Detection Market Size by Country (2025-2030) & (US$ Million)
 Table 35. Europe Circulating Tumor Cell(CTC)Detection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 36. Europe Circulating Tumor Cell(CTC)Detection Market Size by Country (2019-2024) & (US$ Million)
 Table 37. Europe Circulating Tumor Cell(CTC)Detection Market Size by Country (2025-2030) & (US$ Million)
 Table 38. Asia-Pacific Circulating Tumor Cell(CTC)Detection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 39. Asia-Pacific Circulating Tumor Cell(CTC)Detection Market Size by Region (2019-2024) & (US$ Million)
 Table 40. Asia-Pacific Circulating Tumor Cell(CTC)Detection Market Size by Region (2025-2030) & (US$ Million)
 Table 41. Latin America Circulating Tumor Cell(CTC)Detection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 42. Latin America Circulating Tumor Cell(CTC)Detection Market Size by Country (2019-2024) & (US$ Million)
 Table 43. Latin America Circulating Tumor Cell(CTC)Detection Market Size by Country (2025-2030) & (US$ Million)
 Table 44. Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 45. Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Size by Country (2019-2024) & (US$ Million)
 Table 46. Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Size by Country (2025-2030) & (US$ Million)
 Table 47. Rarecyte Company Details
 Table 48. Rarecyte Business Overview
 Table 49. Rarecyte Circulating Tumor Cell(CTC)Detection Product
 Table 50. Rarecyte Revenue in Circulating Tumor Cell(CTC)Detection Business (2019-2024) & (US$ Million)
 Table 51. Rarecyte Recent Development
 Table 52. ANGLE plc Company Details
 Table 53. ANGLE plc Business Overview
 Table 54. ANGLE plc Circulating Tumor Cell(CTC)Detection Product
 Table 55. ANGLE plc Revenue in Circulating Tumor Cell(CTC)Detection Business (2019-2024) & (US$ Million)
 Table 56. ANGLE plc Recent Development
 Table 57. Biocept Inc. Company Details
 Table 58. Biocept Inc. Business Overview
 Table 59. Biocept Inc. Circulating Tumor Cell(CTC)Detection Product
 Table 60. Biocept Inc. Revenue in Circulating Tumor Cell(CTC)Detection Business (2019-2024) & (US$ Million)
 Table 61. Biocept Inc. Recent Development
 Table 62. Bio-Rad Laboratories Inc. Company Details
 Table 63. Bio-Rad Laboratories Inc. Business Overview
 Table 64. Bio-Rad Laboratories Inc. Circulating Tumor Cell(CTC)Detection Product
 Table 65. Bio-Rad Laboratories Inc. Revenue in Circulating Tumor Cell(CTC)Detection Business (2019-2024) & (US$ Million)
 Table 66. Bio-Rad Laboratories Inc. Recent Development
 Table 67. Fluxion Biosciences Inc. Company Details
 Table 68. Fluxion Biosciences Inc. Business Overview
 Table 69. Fluxion Biosciences Inc. Circulating Tumor Cell(CTC)Detection Product
 Table 70. Fluxion Biosciences Inc. Revenue in Circulating Tumor Cell(CTC)Detection Business (2019-2024) & (US$ Million)
 Table 71. Fluxion Biosciences Inc. Recent Development
 Table 72. F. Hoffmann-La Roche AG Company Details
 Table 73. F. Hoffmann-La Roche AG Business Overview
 Table 74. F. Hoffmann-La Roche AG Circulating Tumor Cell(CTC)Detection Product
 Table 75. F. Hoffmann-La Roche AG Revenue in Circulating Tumor Cell(CTC)Detection Business (2019-2024) & (US$ Million)
 Table 76. F. Hoffmann-La Roche AG Recent Development
 Table 77. Sysmex Europe SE Company Details
 Table 78. Sysmex Europe SE Business Overview
 Table 79. Sysmex Europe SE Circulating Tumor Cell(CTC)Detection Product
 Table 80. Sysmex Europe SE Revenue in Circulating Tumor Cell(CTC)Detection Business (2019-2024) & (US$ Million)
 Table 81. Sysmex Europe SE Recent Development
 Table 82. Qiagen Company Details
 Table 83. Qiagen Business Overview
 Table 84. Qiagen Circulating Tumor Cell(CTC)Detection Product
 Table 85. Qiagen Revenue in Circulating Tumor Cell(CTC)Detection Business (2019-2024) & (US$ Million)
 Table 86. Qiagen Recent Development
 Table 87. Research Programs/Design for This Report
 Table 88. Key Data Information from Secondary Sources
 Table 89. Key Data Information from Primary Sources
 Table 90. Authors List of This Report


List of Figures
 Figure 1. Circulating Tumor Cell(CTC)Detection Picture
 Figure 2. Global Circulating Tumor Cell(CTC)Detection Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Circulating Tumor Cell(CTC)Detection Market Share by Type: 2023 VS 2030
 Figure 4. Epithelial Cell Phenotype Features
 Figure 5. Mesenchymal Cell Phenotype Features
 Figure 6. Mixed Epithelial-Mesenchymal Phenotype Features
 Figure 7. Global Circulating Tumor Cell(CTC)Detection Market Size by Application (2024-2030) & (US$ Million)
 Figure 8. Global Circulating Tumor Cell(CTC)Detection Market Share by Application: 2023 VS 2030
 Figure 9. Cancer Diagnosis Case Studies
 Figure 10. Tumor Dynamic Assessment Case Studies
 Figure 11. Tumor Recurrence Monitoring Case Studies
 Figure 12. Circulating Tumor Cell(CTC)Detection Report Years Considered
 Figure 13. Global Circulating Tumor Cell(CTC)Detection Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 14. Global Circulating Tumor Cell(CTC)Detection Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 15. Global Circulating Tumor Cell(CTC)Detection Market Share by Region: 2023 VS 2030
 Figure 16. Global Circulating Tumor Cell(CTC)Detection Market Share by Players in 2023
 Figure 17. Global Top Circulating Tumor Cell(CTC)Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cell(CTC)Detection as of 2023)
 Figure 18. The Top 10 and 5 Players Market Share by Circulating Tumor Cell(CTC)Detection Revenue in 2023
 Figure 19. North America Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 20. North America Circulating Tumor Cell(CTC)Detection Market Share by Country (2019-2030)
 Figure 21. United States Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. Canada Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Europe Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. Europe Circulating Tumor Cell(CTC)Detection Market Share by Country (2019-2030)
 Figure 25. Germany Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. France Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. U.K. Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. Italy Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Russia Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Nordic Countries Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Asia-Pacific Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Asia-Pacific Circulating Tumor Cell(CTC)Detection Market Share by Region (2019-2030)
 Figure 33. China Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. Japan Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. South Korea Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. Southeast Asia Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. India Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. Australia Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Latin America Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. Latin America Circulating Tumor Cell(CTC)Detection Market Share by Country (2019-2030)
 Figure 41. Mexico Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Brazil Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Share by Country (2019-2030)
 Figure 45. Turkey Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. Saudi Arabia Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. UAE Circulating Tumor Cell(CTC)Detection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 48. Rarecyte Revenue Growth Rate in Circulating Tumor Cell(CTC)Detection Business (2019-2024)
 Figure 49. ANGLE plc Revenue Growth Rate in Circulating Tumor Cell(CTC)Detection Business (2019-2024)
 Figure 50. Biocept Inc. Revenue Growth Rate in Circulating Tumor Cell(CTC)Detection Business (2019-2024)
 Figure 51. Bio-Rad Laboratories Inc. Revenue Growth Rate in Circulating Tumor Cell(CTC)Detection Business (2019-2024)
 Figure 52. Fluxion Biosciences Inc. Revenue Growth Rate in Circulating Tumor Cell(CTC)Detection Business (2019-2024)
 Figure 53. F. Hoffmann-La Roche AG Revenue Growth Rate in Circulating Tumor Cell(CTC)Detection Business (2019-2024)
 Figure 54. Sysmex Europe SE Revenue Growth Rate in Circulating Tumor Cell(CTC)Detection Business (2019-2024)
 Figure 55. Qiagen Revenue Growth Rate in Circulating Tumor Cell(CTC)Detection Business (2019-2024)
 Figure 56. Bottom-up and Top-down Approaches for This Report
 Figure 57. Data Triangulation
 Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Free Circulating Tumor Cell Detection Market Research Report 2024
Global CTC Detection Market Research Report 2025
Global Circulating Tumor Cells CTCs Detectors Market Research Report 2024
Global Circulating Tumor Cell Diagnostics Market Insights Forecast to 2030
Global Circulating Tumor Cell CTC Detector Market Research Report 2024
Circulating Tumor Cell Capture Instrument Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Circulating Tumor Cell Detection System Market Research Report 2024
Global Cell free Tumor DNA Detection Market Research Report 2025
Global Circulating Tumor Cells Market Research Report 2025
Global Circulating Tumor Cells and Cancer Stem Cells Market Research Report 2024
Circulating Tumor Cell CTC Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global ctDNA Detection Market Research Report 2025
Global Circulating Tumor Cells CTCs and Cancer Stem Cells CSCs Market Insights Forecast to 2030
Circulating Tumor Cell CTC Detection Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global ctDNA Detection Kit Market Research Report 2024
Global Circulating Tumor DNA Diagnostics Market Research Report 2025
Circulating Tumor Cells CTC Liquid Biopsy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Circulating Tumour DNA ctDNA Testing Market Research Report 2024
Global Cell Free Circulating Tumor DNA ctDNA Market Research Report 2024
Global Liquid Biopsy Products Market Insights Forecast to 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28I6901
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22R9736
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29A2598
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions